CURI vs GTN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CURI

35.2
AI Score
VS
GTN Wins

GTN

37.9
AI Score

Investment Advisor Scores

CURI

35score
Recommendation
SELL

GTN

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CURI GTN Winner
Revenue 38.41M 2.58B GTN
Net Income 7.55M 72.00M GTN
Net Margin 19.7% 2.8% CURI
Operating Income 7.64M 483.00M GTN
ROE 18.2% 3.3% CURI
ROA 11.2% 0.7% CURI
Total Assets 67.47M 10.49B GTN
Cash 5.38M 154.00M GTN
Current Ratio 0.78 0.92 GTN

Relative Price Performance (Last 90 Days)

CURI 1M: -13.9% · 3M: -13.9% GTN 1M: +31.4% · 3M: +20.2%

Current Technical Phase

CURI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $2.41

GTN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 76.9 · Price: $5.82

Fundamentals Snapshot

Metric CURI GTN
Market Cap — —
Forward P/E 7.8 -8.3
Trailing P/E — 17.5
Revenue (TTM) — —
Revenue Growth 0.2% 0.3%
Gross Margin 0.6% 0.3%
Operating Margin 0.4% 0.3%
EPS 0.00 0.32
Dividend Yield 0.13% 0.07%

Frequently Asked Questions

Based on our detailed analysis, GTN is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.